Which statement about TLS prophylaxis is correct?

Prepare for the CPHON Chemotherapy Test with interactive materials. Use flashcards and multiple choice questions with hints and explanations. Get exam-ready!

Multiple Choice

Which statement about TLS prophylaxis is correct?

Explanation:
TLS prophylaxis targets uric acid to prevent kidney injury from tumor lysis. Allopurinol blocks xanthine oxidase, which reduces the formation of uric acid from purines, so less uric acid is produced. It does not remove uric acid that’s already in the body. Rasburicase, by contrast, is an enzyme that converts existing uric acid into allantoin, a more soluble compound, leading to a rapid drop in uric acid levels. Because of these different actions, the statement that allopurinol prevents uric acid formation and rasburicase rapidly metabolizes existing uric acid reflects their distinct roles most accurately. Rasburicase does not prevent formation, and allopurinol does not metabolize existing uric acid, so the other descriptions don’t fit.

TLS prophylaxis targets uric acid to prevent kidney injury from tumor lysis. Allopurinol blocks xanthine oxidase, which reduces the formation of uric acid from purines, so less uric acid is produced. It does not remove uric acid that’s already in the body. Rasburicase, by contrast, is an enzyme that converts existing uric acid into allantoin, a more soluble compound, leading to a rapid drop in uric acid levels. Because of these different actions, the statement that allopurinol prevents uric acid formation and rasburicase rapidly metabolizes existing uric acid reflects their distinct roles most accurately. Rasburicase does not prevent formation, and allopurinol does not metabolize existing uric acid, so the other descriptions don’t fit.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy